Literature DB >> 22415793

Formal synthesis of (-)-englerin A and cytotoxicity studies of truncated englerins.

Jing Xu1, Eduardo J E Caro-Diaz, Ayse Batova, Steven D E Sullivan, Emmanuel A Theodorakis.   

Abstract

An efficient formal synthesis of (-)-englerin A (1) is reported. The target molecule is a recently isolated guaiane sesquiterpene that possesses highly potent and selective activity against renal cancer cell-lines. Our enantioselective strategy involved the construction of the BC ring system of compound 1 through a Rh(II)-catalyzed [4+3] cycloaddition reaction followed by subsequent attachment of the A ring through an intramolecular aldol condensation reaction. As such, this strategy allows the synthesis of truncated englerins. Evaluation of these analogues with the A498 renal cancer cell-line suggested that the A ring of englerin is crucial to its antiproliferative activity. Moreover, evaluation of these analogues led to the identification of potent growth-inhibitors of CEM cells with GI(50) values in the range 1-3 μM.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415793      PMCID: PMC3338859          DOI: 10.1002/asia.201101021

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  39 in total

1.  Stereoselective synthesis of (-)-acanthoic acid.

Authors:  T Ling; B A Kramer; M A Palladino; E A Theodorakis
Journal:  Org Lett       Date:  2000-07-13       Impact factor: 6.005

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 3.  Ruthenium-based heterocyclic carbene-coordinated olefin metathesis catalysts.

Authors:  Georgios C Vougioukalakis; Robert H Grubbs
Journal:  Chem Rev       Date:  2010-03-10       Impact factor: 60.622

4.  Total synthesis and absolute configuration of the guaiane sesquiterpene englerin A.

Authors:  Matthieu Willot; Lea Radtke; Daniel Könning; Roland Fröhlich; Viktoria H Gessner; Carsten Strohmann; Mathias Christmann
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 5.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.

Authors:  Bettina Siedle; Alfonso J García-Piñeres; Renato Murillo; Jürgen Schulte-Mönting; Victor Castro; Peter Rüngeler; Christoph A Klaas; Fernando B Da Costa; Wanda Kisiel; Irmgard Merfort
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

Review 8.  Renal cell carcinoma: current status and emerging therapies.

Authors:  Eric C Nelson; Christopher P Evans; Primo N Lara
Journal:  Cancer Treat Rev       Date:  2007-02-27       Impact factor: 12.111

9.  Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro- 2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate enantiomers.

Authors:  Rudong Shan; Susan E Howlett; Edward E Knaus
Journal:  J Med Chem       Date:  2002-02-14       Impact factor: 7.446

Review 10.  Metastatic renal cell carcinoma: recent advances and current therapeutic options.

Authors:  Andres Jan Schrader; Rainer Hofmann
Journal:  Anticancer Drugs       Date:  2008-03       Impact factor: 2.248

View more
  8 in total

Review 1.  Englerins: A Comprehensive Review.

Authors:  Zhenhua Wu; Senzhi Zhao; David M Fash; Zhenwu Li; William J Chain; John A Beutler
Journal:  J Nat Prod       Date:  2017-02-07       Impact factor: 4.050

2.  Biological Effects of Modifications of the Englerin A Glycolate.

Authors:  Sarath P D Seenadera; Sarah A Long; Rhone Akee; Gabriela Bermudez; Gregory Parsonage; Jonathan Strope; Cody Peer; W Douglas Figg; Kathlyn A Parker; David J Beech; John A Beutler
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

Review 3.  Cycloaddition reactions of enoldiazo compounds.

Authors:  Qing-Qing Cheng; Yongming Deng; Marianne Lankelma; Michael P Doyle
Journal:  Chem Soc Rev       Date:  2017-08-29       Impact factor: 54.564

4.  A formal synthesis of (-)-englerin A by relay ring closing metathesis and transannular etherification.

Authors:  Jungyong Lee; Kathlyn A Parker
Journal:  Org Lett       Date:  2012-05-07       Impact factor: 6.005

5.  Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition.

Authors:  Zhenhua Wu; Jean-Simon Suppo; Sarka Tumova; Jonathan Strope; Fernando Bravo; Melody Moy; Ethan S Weinstein; Cody J Peer; William D Figg; William J Chain; Antonio M Echavarren; David J Beech; John A Beutler
Journal:  ACS Med Chem Lett       Date:  2020-08-03       Impact factor: 4.345

6.  Englerin a selectively induces necrosis in human renal cancer cells.

Authors:  Florian J Sulzmaier; Zhenwu Li; Mika L Nakashige; David M Fash; William J Chain; Joe W Ramos
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

7.  Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy.

Authors:  Richard T Williams; Alice L Yu; Mitchell B Diccianni; Emmanuel A Theodorakis; Ayse Batova
Journal:  J Exp Clin Cancer Res       Date:  2013-08-20

8.  Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.

Authors:  Ayse Batova; Diego Altomare; Kim E Creek; Robert K Naviaux; Lin Wang; Kefeng Li; Erica Green; Richard Williams; Jane C Naviaux; Mitchell Diccianni; Alice L Yu
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.